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CD4+ T cells are an essential component of the 
adaptive immune system. Upon activation by 
APCs in the periphery, naive CD4+ T cells dif-
ferentiate into effector Th cells that are special-
ized to produce specific cytokines and/or exhibit 
specific effector functions. In addition to the Th1 
and Th2 cell lineages, a third subset of CD4+  
T cells has been characterized by its expres-
sion of IL-17, hence the designation Th17 cells 
(Harrington et al., 2005; Park et al., 2005). The 
essential role of Th17 cells in mucosal and epi-
thelial host defense has been demonstrated in 
many studies using various infection and disease 
models (Korn et al., 2009). Th17 cells have also 
been shown to be critical in the pathogenesis   
of several inflammatory diseases, leading to suc-
cessful clinical trials targeting Th17 cells in pso-
riasis and Crohn’s disease (Steinman, 2010).
Th17 cells produce IL-17F and IL-22, in ad-
dition to IL-17 (also known as IL-17A), and are 
identified by the lineage-specific transcription 
factors, ROR-t (retinoid-related orphan recep-
tor t) and ROR- (Ivanov et al., 2006; Yang   
et  al.,  2008).  IL-6  and TGF-  were  initially 
shown to be indispensible for in vitro Th17 cell 
differentiation from naive CD4+ T cells, whereas 
IL-23 is important for the maintenance and sur-
vival of the lineage in vivo (McGeachy and Cua, 
2008). However, a TGF-–independent alterna-
tive pathway of Th17 cell generation has recently 
been identified, suggesting heterogeneity in 
Th17 cells (Ghoreschi et al., 2010).
In addition to its production by Th17 cells, 
IL-17 is a proinflammatory cytokine also pro-
duced by many innate immune cells (Cua and 
Tato, 2010), including NKT cells (Michel et al., 
2007) and  T cells (Martin et al., 2009), that 
gain IL-17 competency during thymic develop-
ment.  Recently,  a  population  of  CD4  single- 
positive (SP) thymocytes was shown to produce 
IL-17, and it was suggested that these cells are 
generated in the thymus (Marks et al., 2009; 
Tanaka et al., 2009). However, the developmental 
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CD4+ T helper 17 (Th17) cells play a critical role in the adaptive immune response against 
extracellular pathogens. Most studies to date have focused on understanding the differen-
tiation of Th17 cells from naive CD4+ T cells in peripheral effector sites. However, Th17 
cells are present in the thymus. In this study, we demonstrate that a population of Th17 
cells, natural Th17 cells (nTh17 cells), which acquire effector function during development 
in the thymus before peripheral antigen exposure, shows preferential usage of T cell recep-
tor V3. nTh17 cells are dependent on major histocompatibility complex (MHC) class II for 
thymic selection, yet unlike conventional CD4+ T cells, MHC class II expression on thymic 
cortical epithelium is not sufficient for their development, rather expression on medullary 
epithelium is necessary. Differential signaling requirements for IL-17 priming further 
distinguish nTh17 from conventional Th17 cells. Collectively, our findings define a Th17 
population, poised to rapidly produce cytokines, that is developmentally distinct from 
conventional Th17 cells and that potentially functions at the interface of innate and 
adaptive immunity.
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the publication date (see http://www.rupress.org/terms). After six months it is 
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the thymic origin of cells preferentially expressing this TCR 
V family member (Fig. 2 B). In contrast, Th17 cells isolated 
from the small intestinal lamina propria (LP), a physiological 
site enriched with Th17 cells, did not show skewing toward 
TCR V3 (Fig. 2 C). Moreover, among the TCR Vs that 
were analyzed, splenic and small intestinal LP Th17 cells showed 
no difference in TCR V usage compared with non-Th17 
CD4+ T cells from the same sites (Fig. 2 C and Fig. S2). Further 
analysis of RAG2-GFP mice revealed that, with age, a signifi-
cant population of IL-17+ GFPlo cells emerged and that this 
population had even more highly skewed V3 usage than their 
requirements and characteristics that distinguish this popula-
tion from peripherally induced conventional Th17 cells are 
not well defined.
The  present  study  utilizes  fetal  thymic  organ  culture 
(FTOC) to demonstrate definitively that a population of Th17 
cells indeed develops in the thymus. These cells show unique 
characteristics in TCR gene usage and MHC class II require-
ments compared with those of conventional Th17 cells.   
Finally, a TCR signaling mutant reveals differential signal-
ing  requirements for the generation of these two distinct 
Th17 cell populations. Thus, our data define these natural 
Th17 cells (nTh17 cells) as a Th17 cell population that is dis-
tinct from conventional Th17 cells.
RESULTS AND DISCUSSION
We confirmed an earlier report (Marks et al., 2009) of an   
IL-17–expressing population within the CD4SP thymocyte 
compartment in WT mice (Fig. 1 A). The thymic IL-17+ 
CD4SP population is distinct from NKT and  T cells, as this 
population is still present in SAP (SLAM-associated protein)- 
deficient (Fig. S1 A; Nichols et al., 2005) and  TCR KO 
mice (Fig. S1 B), which lack NKT and  T cells, respectively. 
We demonstrate that a significant proportion of these IL-17–
producing CD4SP thymocytes coexpress IL-17F, and, as re-
ported (Marks et al., 2009), have other characteristic Th17 
lineage properties including IL-22 message, expression of the 
transcription factor ROR-t, CCR6 (chemokine receptor 6), 
IL-23R, and CD44, a marker present on activated/memory 
cells and innate immune cells (Fig. 1, A and B). Moreover, 
thymic Th17 cells do not express Foxp3 (forkhead box p3)   
or IFN- (key features of CD4+ regulatory T cells [Treg cells] 
or Th1 cells, respectively), indicating that their transcriptional 
and cytokine program is specific to the Th17 lineage. Simi-
larly, we found that in young RAG2-GFP mice, in which 
GFP marks newly generated thymocytes, virtually all thymic 
IL-17–producing CD4SP T cells are GFPhi, indicating that 
they are newly generated in the thymus (discussed further 
below; Fig. 2 D). As a more rigorous approach to analyze the 
ontogeny of thymic Th17 cells, we used FTOC, which re-
vealed significant numbers of these cells at day 8 (Fig. 1 C), 
when the CD4SP population was clearly definable. These ex-
periments demonstrate that a population of nTh17 cells de-
velops in the thymus with the inherent ability to produce 
cytokines without the need for peripheral TCR-induced dif-
ferentiation, thus sharing properties with other lymphocytes 
with innate-like characteristics.
Innate lymphocyte lineages that arise in the thymus often 
have a unique or skewed TCR repertoire (Lantz and Bendelac, 
1994; Azuara et al., 1997). We examined the TCR reper-
toire of nTh17 cells by analyzing their TCR  chain variable 
region  (TCR  V)  usage.  nTh17  cells  showed  preferential   
usage of TCR V3 compared with non-Th17 CD4SP thymo-
cytes (11.5 ± 0.9% vs. 2.55 ± 0.10%), whereas expression of 
other V genes was similar or slightly decreased in a comple-
mentary manner (e.g., V6; Fig. 2 A). This pattern was also ob-
served in nTh17 cells that developed in FTOC, thus verifying 
Figure 1.  A population of Th17 cells develops in the thymus.  
(A) Thymocytes from C57BL/6 WT mice were stimulated ex vivo with PMA/
ionomycin in the presence of brefeldin A and stained for surface markers 
and intracellular expression of IL-17A, IL-17F, and ROR-t. Flow cytom-
etry plots are gated on CD4SPTCR-+TCR-CD1d-tetramer cells (first 
row). Histograms show the expression of the indicated transcription fac-
tor or surface marker on CD4SPTCR-+TCR-CD1d-tetramerIL-17A+ 
thymocytes (solid black line). (B) Quantitative RT-PCR analysis of messen-
ger RNA (mRNA) transcripts in thymocyte populations (key) sorted from 
WT mice, relative to GAPDH. Error bars represent SEM. **, P ≤ 0.01;  
***, P ≤ 0.001 (two-tailed Student’s t test). (C) Cells from day 8 culture of 
WT E15 FTOC were stimulated and stained for flow cytometry. Flow cy-
tometry plots are gated on whole thymocytes (left) and CD4SPTCR-+TCR-
CD1d-tetramer cells (right). Histograms are as in A. Data are 
representative of at least three independent experiments with n ≥ 3 mice 
(or FT lobe [C]) per experiment.JEM Vol. 208, No. 11  2203
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were transplanted into lethally irradiated WT hosts (CD45.1+), 
creating a thymic environment in which only the TECs ex-
press MHC class II, the percentage and number of nTh17 
cells were similar to control WT BM chimeras (Fig. 3, A and B). 
These data indicate that MHC class II expression on cortical 
TECs (cTECs) and medullary TECs (mTECs) is sufficient to 
support nTh17 cell development and that there is not an 
absolute requirement for MHC class II expression on hemato-
poietic APCs for the generation of this population. Chimeras 
in which WT BM cells (CD45.1+) were transplanted into 
MHC class II–deficient hosts (CD45.2+) were nearly devoid of 
nTh17 cells (Fig. 3 C), indicating that MHC class II expression 
on hematopoietic cells alone is not sufficient for normal nTh17 
cell selection.
To define the contribution of cTECs versus mTECs in 
nTh17 cell development, we first used K14-A
b mice that   
express MHC class II only on cTECs, whereas mTECs and 
hematopoietic APCs are MHC class II deficient (Laufer et al., 
1996). nTh17 cells were not found in the thymi of K14-A
b 
mice (Fig. 3 D), despite the presence of abundant CD4SP 
thymocytes and the ability of peripheral CD4+ T cells from 
these mice to differentiate into Th17 cells under in vitro Th17- 
polarizing conditions (not depicted). These data suggest that 
expression of MHC class II on thymic cortical epithelium, as 
defined in K14-A
b mice, is not sufficient for selection of 
nTh17 cells. This finding is in contrast to nTreg and conven-
tional CD4+ T cell development for which cortical MHC class 
II expression is sufficient for positive selection (Laufer et al., 
1996; Bensinger et al., 2001; Liston et al., 2008).
To  investigate  the  role  of  mTECs  in 
MHC class II–mediated nTh17 selection, 
we  analyzed  thymocytes  from  C2TAkd 
mice, which have greatly diminished MHC 
class II expression specifically on mTECs 
because of targeted knockdown of the MHC 
class II transactivator, CIITA (Hinterberger   
IL-17+ GFPhi counterparts (Fig. 2 D). These data indicate 
preferential recirculation of V3+ nTh17 cells to the thymus 
and/or preferential retention of this subset. The lack of V3 
skewing among Th17 cells in the periphery could be caused   
by differential homing of nTh17 versus conventional Th17 
cells and/or differences in the expansion of these populations 
at particular organ sites. It has been suggested that nTh17 cells 
preferentially home to the small intestinal LP (Marks et al., 
2009), but whether these cells represented nTh17 cells or a com-
bination of natural and conventional Th17 cells was unclear.
The innate-like properties and skewed V usage prompted 
us to explore the requirements for nTh17 cell development. 
Thymic selection occurs via interactions between the TCR 
and  MHC  molecules  expressed  on  thymic  epithelial  cells 
(TECs) and hematopoietic APCs (Klein et al., 2009). Because 
conventional CD4+ T cells are selected on MHC class II, we 
investigated the role for this restricting element in nTh17 cell 
development using MHC class II–deficient mice. No nTh17 
cells were present in these mice, indicating that selection of 
nTh17 cells is MHC class II dependent (not depicted). In ad-
dition to the identity of the selecting ligand, determining the 
specific thymic compartment (cortex vs. medulla) and cell type 
(epithelium vs. hematopoietic cells) presenting the ligand has 
provided insight into understanding the development of vari-
ous lymphocyte lineages. To determine the role of radioresis-
tant TECs versus radiosensitive hematopoietic cells in nTh17 
cell selection, we generated radiation BM chimeras with MHC 
class II–deficient mice either as BM donors or hosts. In BM 
chimeras in which MHC class II–deficient BM cells (CD45.2+) 
Figure 2.  nTh17 cells show preferential usage 
of TCR V3. (A–C) CD4SP thymocytes (6–8-wk-old 
mice [A] or E15 FTOC d8 [B]) or CD4+ T cells isolated 
from the small intestinal LP (C) of WT (B6) mice 
were assessed for the proportion of cells express-
ing the indicated TCR V chain in IL-17A+ versus  
IL-17A cells. Pooled data from three independent 
experiments with n ≥ 3 mice (or FT lobe [B]) per 
experiment; bars and error bars represent mean ± 
SEM. *, P ≤ 0.05; ***, P ≤ 0.001 (two-way ANOVA 
followed by Bonferroni post-tests). (D) GFP expres-
sion of indicated populations from 6- and 16-wk-
old RAG2-GFP mice. Percentage (mean ± SEM) of 
GFPlo cells among nTh17 cells in 16-wk-old mice is 
shown. Graph represents the proportion of V3+ 
cells in the indicated thymocyte populations (key) in 
16-wk-old mice. Data are from three independent 
experiments with n ≥ 9 mice per group. Bars and 
error bars represent mean ± SEM. *, P ≤ 0.05;  
***, P ≤ 0.001 (one-way ANOVA followed by Tukey’s 
post-tests).2204 A distinct subset of Th17 cells | Kim et al.
(Jordan et al., 2008). To test whether diminished TCR sig-
naling affects the development of nTh17 cells, we examined 
thymi of mice harboring the SLP-76 Y145F mutation (Y145F 
mice). Interestingly, these mice had a marked increase in the 
proportion and absolute number of nTh17 cells compared 
with WT mice (Fig. 4, A and B). nTh17 cells in Y145F mice 
were phenotypically similar to nTh17 cells from WT mice 
with respect to cytokine potential and expression of cell sur-
face markers (Fig. S3, A and B). They developed in FTOC 
with an increased frequency and number compared with 
WT (Fig. S3, C and D) and displayed preferential usage of 
TCR V3 (Fig. S3 E). It is unclear why Y145F mice are en-
riched for nTh17 cells because agonist peptides have been 
implicated in their development (Marks et al., 2009). We 
speculate that the altered responsiveness of Y145F thymo-
cytes results in selection of CD4SP cells that would otherwise 
largely be negatively selected. However, to rule out the pos-
sibility that contribution of cell-extrinsic factors drive en-
hanced nTh17 development in Y145F mice, we generated 
radiation mixed BM chimeras in which WT (Thy1.1+) and 
Y145F or WT (CD45.2+) BM cells were mixed and trans-
planted into lethally irradiated WT (CD45.1+Thy1.2+) host 
mice. Regardless of the chimerism, which can affect the de-
gree of possible extrinsic factors, thymocytes derived from 
Y145F BM had an increased proportion of nTh17 cells com-
pared with WT donor BM-derived thymocytes that had de-
veloped in the same thymic environment (Fig. 4, C and D). 
These data indicate that the enrichment of nTh17 cells in 
Y145F thymus is a cell-intrinsic property. This finding is in 
contrast to a CD8+ innate-like lymphocyte population that 
has recently been shown to be increased in these mice via a 
cell-extrinsic mechanism (Gordon et al., 2011).
Despite the enrichment of thymic nTh17 
cells, surprisingly, CD4+ T cells from the small 
intestinal LP of Y145F mice showed greatly 
reduced IL-17 production and ROR-t ex-
pression compared with WT LP cells (Fig. 5, 
A and B). Lack of Th17 cells in the Y145F 
et al., 2010). nTh17 cells were nearly absent from thymi of 
C2TAkd mice, demonstrating that MHC class II expression 
on mTECs is necessary for nTh17 cell development and that 
combined MHC class II expression on cTECs and hemato-
poietic APCs cannot compensate for loss of MHC class II   
on mTECs. This observation is again in contrast to the re-
quirements for selection of conventional CD4+ and nTreg 
cells, as these cell types are present in elevated frequencies in 
C2TAkd  mice  (Hinterberger  et  al.,  2010).  Expression  of 
MHC class II in K14-A
b mice is diminished compared with 
WT mice, presenting the possibility that lack of nTh17 cell 
generation could be the result of low MHC class II expres-
sion. However, C2TAkd mice have WT levels of MHC class II 
on cTECs, yet this pattern of expression is not sufficient   
for nTh17 cell selection. Collectively, these data show that 
MHC class II expression on cTECs, while sufficient for nTreg 
and conventional CD4+ T cell selection, is not sufficient for 
nTh17 cell development; rather, MHC class II expression on 
mTECs appears to play a critical role in nTh17 cell develop-
ment.  Further  studies  are  required  to  determine  whether 
mTECs are sufficient for the generation of nTh17 cells and to 
dissect how MHC class II:peptide presentation, alone or in 
concert with soluble factors and/or co-stimulatory molecules, 
dictates nTh17 lineage commitment.
The strength of TCR signaling is known to affect the de-
velopment of many lymphocyte lineages, including  T cells 
(Hayes et al., 2005) and CD4+ nTreg cells (Jordan et al., 2001). 
SLP-76 (SH2 domain–containing leukocyte protein of 76 kD) 
is a critical adaptor protein for thymocyte selection and TCR 
signaling (Koretzky et al., 2006). Recently, we showed 
that mutation of tyrosine 145 of SLP-76 (Y145F) dampens 
TCR signal strength, resulting in altered thymocyte selection 
Figure 3.  MHC class II expression on thymic 
medullary epithelium is necessary for selection of 
nTh17 cells. (A) Thymocytes from BM chimeras were 
stimulated and analyzed. Representative flow cytom-
etry plots gated on live thymocytes (top) or 
CD4SPTCR-+TCR-NK1.1 cells (bottom) from 
donor BM-derived cells (CD45.2+) are shown.  
(B and C) The proportion (left) or number (right) of 
nTh17 cells of BM donor origin in indicated chimeras 
is shown (mean ± SEM; p-values are from two-tailed 
Student’s t test). Data are from two independent 
experiments with a total of n = 6–10 mice per group.  
(D and E) Thymocytes from K14-A
b (D) and C2TAkd 
mice (E) were stimulated and analyzed. Flow cytom-
etry plots are gated on live thymocytes (left) and 
CD4SPTCR-+TCR-NK1.1 cells (right). Data are 
representative of at least two independent experi-
ments with a total of n ≥ 4 mice per group.JEM Vol. 208, No. 11  2205
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T cells showed intact IL-17 production in Y145F host, thus 
again  supporting  the  idea  that  the  defective  peripheral 
Th17 phenotype in Y145F mice is via a cell-intrinsic mecha-
nism (Fig. 5 E).
Collectively, these data demonstrate that nTh17 develop-
ment and peripheral Th17 conversion have different signaling 
requirements. The biochemical mechanism underlying pre-
served nTh17 generation in the face of defective conventional 
Th17 cell differentiation in Y145F mice is not known. It is 
possible that IL-17–producing cells are present among Y145F 
thymocytes because high affinity T cells are still represented 
within the developing Y145F repertoire, allowing for com-
pensation of defective TCR signal transduction. Alternatively, 
the differences in signaling pathways between thymocytes and 
LP could be caused by the inability of Y145F peripheral 
CD4+ T cells to differentiate into Th17 cells, a defect in 
Y145F CD4+ T cells homing to peripheral sites, or an altered 
gut environment resulting from an unappreciated effect of 
the Y145F mutation. Naive (CD44loCD62Lhi) Y145F pe-
ripheral CD4+ T cells showed a severe defect in IL-17 pro-
duction compared with WT cells when cultured in vitro under 
conditions that promote Th17 cell differentiation (Fig. 5 C), 
similar to T cells deficient in the SLP-76 binding partner Itk 
(IL-2–inducible T cell kinase; Gomez-Rodriguez et al., 2009).   
In contrast, in vitro differentiation to Th1 or Th2 lineages was 
intact (Fig. S4, A and B), indicating that Y145F CD4+ T cells 
are not globally defective in cytokine production or differen-
tiation into effector subsets. Consistent with these findings, 
Y145F BM-derived CD4+ T cells showed defective IL-17 
production in mixed BM chimeras in the presence of WT 
BM-derived APCs and a WT gut environment, indicating 
that the Y145F peripheral CD4+ LP T cells have an intrinsic 
defect in Th17 lineage commitment (Fig. 5 D). Because the 
number of CD4+ T cells in the small intestinal LP of Y145F 
mice is comparable with that of WT mice and splenic CD4+ 
IL-17+ T cells are present in these mice, we speculate that de-
fective trafficking is unlikely (not depicted). To address the 
permissiveness of the Y145F intestinal environment, we gen-
erated BM chimeras in which WT BM was transplanted into 
irradiated  Y145F  host.  WT  donor  BM-derived  LP  CD4+  
Figure 4.  Y145F mice show enrichment of thymic nTh17 cells via a 
cell-intrinsic mechanism. (A and B) Thymocytes from WT and Y145F mice 
were stimulated with PMA/ionomycin and analyzed. Representative flow 
cytometry plots gated on CD4SPTCR-+TCR-NK1.1 cells (A) and pooled 
data (B) from at least three independent experiments with n ≥ 3 per experi-
ment are shown. Error bars represent SEM. (C) Thymocytes from mixed BM 
chimeras were stimulated and analyzed. Representative flow cytometry 
plots gated on CD4SP TCR-+TCR-NK1.1 cells showing the percentage 
of IL-17A+ cells among Thy1.1+ or CD45.2+ populations. (D) Pooled data 
representing the proportion of nTh17 cells among CD4SP cells in either WT 
(Thy1.1+)- or Y145F (CD45.2+)-derived thymocytes from WT + Y145F mixed 
BM chimeras (mean ± SEM; p-value from two-tailed Student’s t test). Data 
are from two independent experiments with n ≥ 6 mice per group.
Figure 5.  Y145F CD4+ T cells have an intrinsic defect in periph-
eral Th17 cell differentiation. (A and B) Small intestinal LP cells were 
isolated from WT and Y145F mice, stimulated, and analyzed. Representa-
tive flow plots gated on CD4+CD3+TCR-+ cells (A) and pooled data (B) 
from at least three independent experiments with n ≥ 3 per group in each 
experiment (mean ± SEM; p-value from two-tailed Student’s t test) are 
shown. (C) Naive CD4+ T cells from WT and Y145F mice were isolated by 
cell sorting and cultured with plate-bound anti-CD3/CD28 and TGF-, 
IL-6, IL-23, anti–IL-4, and anti–IFN- for 3 d. Cells were restimulated 
with either anti-CD3/CD28 or PMA/ionomycin with brefeldin A followed 
by intracellular staining for IL-17A. Data are representative of at least 
three independent experiments. (D and E) Small intestinal LP cells from 
mixed BM chimeras (D) or BM chimeras with the indicated hosts (E) were 
stimulated and analyzed. Representative flow cytometry plots gated on 
CD4+CD3+TCR-+ cells showing the percentage of IL-17A+ cells among 
Thy1.1+ or CD45.2+ populations (or donor BM-derived cells [E]) are shown. 
Data are from two independent experiments with n ≥ 6 mice per group 
(D) or one independent experiment with n = 5 mice per group (E).2206 A distinct subset of Th17 cells | Kim et al.
Ex vivo stimulation. Freshly isolated or cultured lymphocytes were stimu-
lated ex vivo for 5 h with 50 ng/ml PMA and 500 ng/ml ionomycin in the 
presence of 1 µg/ml brefeldin A. Cells were then assayed for cytokine produc-
tion by intracellular flow staining.
T cell isolation and differentiation. CD4+ T cells from spleens and lymph 
nodes of the indicated mice were purified by negative selection and mag-
netic separation (Miltenyi Biotec) followed by sorting of naive CD4+CD25 
CD44loCD62Lhi population using the FACSAria II (BD). Cells were activated 
by 1 µg/ml plate-bound anti-CD3 and 5 µg/ml anti-CD28 (both from eBiosci-
ence) in the presence of 5 ng/ml TGF-, 20 ng/ml IL-6, 10 ng/ml IL-23,   
10 µg/ml anti–IL-4, and 10 µg/ml anti–IFN- for Th17 polarization; 50 U/ml   
IL-12 and 10 µg/ml anti–IL-4 for Th1 polarization; and 2,000 U/ml IL-4,   
10 µg/ml anti–IL-12, and 10 µg/ml anti–IFN- for Th2 polarization.
Flow cytometry. The following antibodies were used for surface stain   
(from BD unless noted): anti-CD3-PE-Cy5 or -PB (BioLegend), anti-CD4-
PE-Cy7  or  -FITC,  anti-CD8-PETR  (Invitrogen)  or  -APC-Cy7,  anti- 
CD44-AF700 (BioLegend) or -PE, anti-CD45.1-PE, anti-CD45.2-FITC or 
-PE-Cy7, anti-CD62L-APC, anti-Thy1.1-PE-Cy5 or -PE, anti–TCR-–
APCe780 (eBioscience), anti–TCR-–PE-Cy5, anti-NK1.1-PE-Cy7, anti-
CCR6-AF647  (eBioscience),  and  PBS57-CD1d-tetramer-APC  (National 
Institutes of Health Tetramer Core Facility). For intracellular cytokine or tran-
scription factor expression, staining was performed using Foxp3 staining buf-
fer (eBioscience) according to the manufacturer’s instructions. The following 
antibodies were used (from eBioscience unless noted): anti–ROR-t–PE, 
anti-Foxp3-FITC, anti–IL-17A–AF647 or –PE, anti–IL-17F–FITC, anti–
IFN-–PB (BioLegend), and anti–IL-4–PE-Cy7. Data were acquired using 
the FACS LSR II (BD) and analyzed with FlowJo software (Tree Star).
Real-time PCR. Total RNA was isolated from FACS-purified thymocytes 
using the RNeasy Mini kit (QIAGEN), and cDNA was synthesized with the 
Super Script III First Strand kit (Invitrogen). RT-PCR was performed with 
site-specific primers and probes (Applied Biosystems) with Fast Taq Master 
Mix (Applied Biosystems) on a 7500 Fast Real-Time PCR system (Applied 
Biosystems). For analysis, samples were normalized to GAPDH levels and 
then set relative to the CD4SPCD44loCCR6 population by the relative 
quantification method (CT). The following primers and probes (Applied 
Biosystems) were used: Gapdh, Mm03302249_g1; Il-17f, Mm00521423_m1; 
Il-22, Mm00444241_m1; and Il23r, Mm00519943_m1.
Statistical analysis. P-values were analyzed from Student’s t test, one-
way analysis of variance (ANOVA) followed by Tukey’s post-test, or   
two-way  ANOVA  followed  by  the  Bonferroni  post-test  using  Prism 
(GraphPad Software).
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naive peripheral T cells and/or the requirements for IL-17   
induction in these cell populations may be fundamentally dif-
ferent. Indeed, recent publications suggest that different 
IL-17–producing T cell populations have differential require-
ments for TCR and/or cytokine-initiated signal transduction 
for Th17 lineage differentiation (Tanaka et al., 2009; Ghoreschi 
et al., 2010; Powolny-Budnicka et al., 2011).
We have described a population of Th17 cells with innate 
immune cell characteristics. These cells acquire effector func-
tion during thymic development, show a skewed TCR gene 
usage, and have positive selection requirements distinct from 
that of conventional T cells. Using a TCR signaling mutant, 
we further demonstrate that the nTh17 cells constitute a pop-
ulation distinct from conventional Th17 cells, as these mice 
have enriched nTh17 cells in the thymus but show markedly 
defective conventional Th17 cell differentiation in the pe-
riphery because of cell-intrinsic mechanisms. Understanding 
the biology of nTh17 cells will provide insight into recently 
identified  Th17  cells  in  human  thymi  and  umbilical  cord 
blood (Cosmi et al., 2008; Kleinschek et al., 2009) and may 
also shed light on the role of IL-17 in bridging innate and 
adaptive immune responses.
MATERIALS AND METHODS
Mice.  C57BL/6J,  B6.PL-Thy1a/CyJ,  FVB-Tg(Rag2-EGFP)1Mnz/J,  and 
B6.129P2-Tcrdtm1Mom/J ( TCR KO) mice were purchased from the Jackson 
Laboratory. B6 CD45.1, Ab1tm1Gru (MHC class II KO, IA/) mice were 
purchased from Taconic. SLP-76 Y145F (Jordan et al., 2008), SAP/ (pro-
vided by K. Nichols, Children’s Hospital of Philadelphia, Philadelphia, PA; 
Yin et al., 2003), K14-A
b (provided by T. Laufer, University of Pennsylvania, 
Philadelphia, PA; Laufer et al., 1996), and C2TAkd (provided by L. Klein, 
Ludwig-Maximilians-University, Munich, Germany; Hinterberger et al., 2010) 
mice were previously described. Animals were housed at the University of 
Pennsylvania, and experiments were performed in accordance with protocols 
approved by the Institutional Animal Care and Use Committee.
FTOC. Fetal thymic lobes were dissected from embryonic day (E) 15 em-
bryos and cultured on sponge-supported filter membranes (Gelfoam absorb-
able gelatin sponge, USP 7 mm [Pfizer]; Nuclepore track-etched membranes, 
0.8 µm–13 mm round [GE Healthcare]) at an interphase between 5% CO2-
humidified air and IMDM (10% FCS/50 µM 2-mercaptoethanol/2 mM   
l-glutamine/penicillin/streptomycin). Medium was changed after 3 d of culture.
TCR V analysis. Proportion of the indicated TCR V among the ana-
lyzed populations was assessed using TCR V screening panel (BD) and 
flow cytometry.
Radiation BM chimeras. Recipient mice were irradiated with 950 rads 
and injected i.v. with a mixture of T cell–depleted (magnetic bead depletion; 
QIAGEN) BM from the indicated donor mice. Recipients were reconsti-
tuted with 2 × 106 BM cells and maintained on sterile water with sulfa-
methoxazole/trimethoprim for 2–3 wk. Chimeras were analyzed at 5–6 wk 
(MHC class II KO BM into WT hosts) or 8 wk (all other BM chimeras)   
after transplantation.
Isolation of LP lymphocytes. The small intestine was dissected, cleared 
from mesentery, fat, and Peyer’s patches, washed in PBS, and cut into pieces. 
After incubation in RPMI 1640 with EDTA, epithelial cells were separated, 
and the tissue was digested with Liberase TM and DNase I (both from 
Roche) at 37°C. LP lymphocytes were recovered after filtering the digested 
tissue through a 70-µm cell strainer and washed in media.JEM Vol. 208, No. 11  2207
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